Published in J Cell Biol on July 01, 1992
Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. Proc Natl Acad Sci U S A (1996) 2.52
Lipid modifications of G proteins: alpha subunits are palmitoylated. Proc Natl Acad Sci U S A (1993) 2.32
Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci U S A (1997) 1.97
The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer. J Exp Med (1993) 1.71
Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest (1993) 1.65
The role of the synthetic enzyme GAD65 in the control of neuronal gamma-aminobutyric acid release. Proc Natl Acad Sci U S A (1999) 1.63
Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci U S A (1999) 1.50
Demonstration of functional coupling between gamma -aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles. Proc Natl Acad Sci U S A (2003) 1.43
Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J Exp Med (1994) 1.36
Pancreatic beta cells cultured from individual preneoplastic foci in a multistage tumorigenesis pathway: a potentially general technique for isolating physiologically representative cell lines. Mol Cell Biol (1993) 1.34
Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J Exp Med (1993) 1.34
Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc Natl Acad Sci U S A (1993) 1.32
Association of GAD-65, but not of GAD-67, with the Golgi complex of transfected Chinese hamster ovary cells mediated by the N-terminal region. Proc Natl Acad Sci U S A (1993) 1.22
Novel diabetes autoantibodies and prediction of type 1 diabetes. Curr Diab Rep (2013) 1.13
Palmitoyl protein thioesterase-1 deficiency impairs synaptic vesicle recycling at nerve terminals, contributing to neuropathology in humans and mice. J Clin Invest (2008) 1.12
A combination of three distinct trafficking signals mediates axonal targeting and presynaptic clustering of GAD65. J Cell Biol (2002) 1.10
Amino acid residues 24-31 but not palmitoylation of cysteines 30 and 45 are required for membrane anchoring of glutamic acid decarboxylase, GAD65. J Cell Biol (1994) 1.07
Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient. J Clin Invest (1996) 1.03
Vesicular and plasma membrane transporters for neurotransmitters. Cold Spring Harb Perspect Biol (2012) 1.02
Two distinct mechanisms target GAD67 to vesicular pathways and presynaptic clusters. J Cell Biol (2010) 1.02
A signal located within amino acids 1-27 of GAD65 is required for its targeting to the Golgi complex region. J Cell Biol (1994) 1.02
Islet autoantigens: structure, function, localization, and regulation. Cold Spring Harb Perspect Med (2012) 1.02
Discovery of native autoantigens via antigen surrogate technology: application to type 1 diabetes. ACS Chem Biol (2014) 0.95
Encephalitis and epilepsy. Semin Immunopathol (2009) 0.91
Motifs and structural fold of the cofactor binding site of human glutamate decarboxylase. Protein Sci (1998) 0.91
Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias. Cerebellum (2016) 0.88
Pharmacological and biochemical aspects of GABAergic neurotransmission: pathological and neuropsychobiological relationships. Cell Mol Neurobiol (2004) 0.87
Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes. J Clin Invest (1996) 0.85
GAD65 autoantibodies and its role as biomarker of Type 1 diabetes and Latent Autoimmune Diabetes in Adults (LADA). Drugs Future (2011) 0.84
Mice lacking Gad2 show altered behavioral effects of ethanol, flurazepam and gabaxadol. Addict Biol (2010) 0.83
Dynamic regulation of glycine-GABA co-transmission at spinal inhibitory synapses by neuronal glutamate transporter. J Physiol (2013) 0.82
An AP-3-dependent mechanism drives synaptic-like microvesicle biogenesis in pancreatic islet beta-cells. Am J Physiol Endocrinol Metab (2010) 0.82
GAD65 Positive Autoimmune Limbic Encephalitis: A Case Report and Review of Literature. J Clin Med Res (2012) 0.81
Calpain cleavage of brain glutamic acid decarboxylase 65 is pathological and impairs GABA neurotransmission. PLoS One (2012) 0.79
Compartmentalization of GABA synthesis by GAD67 differs between pancreatic beta cells and neurons. PLoS One (2015) 0.79
Antigen presentation of detergent-free glutamate decarboxylase (GAD65) is affected by human serum albumin as carrier protein. J Immunol Methods (2008) 0.79
Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions. J Neurol (2014) 0.78
In intact islets interstitial GABA activates GABA(A) receptors that generate tonic currents in α-cells. PLoS One (2013) 0.78
Aberrant Accumulation of the Diabetes Autoantigen GAD65 in Golgi Membranes in Conditions of ER Stress and Autoimmunity. Diabetes (2016) 0.76
A membrane form of brain L-glutamate decarboxylase: identification, isolation, and its relation to insulin-dependent mellitus. Proc Natl Acad Sci U S A (1994) 0.75
Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias. J Immunol Res (2017) 0.75
Immune-mediated cerebellar ataxias: from bench to bedside. Cerebellum Ataxias (2017) 0.75
Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem (1981) 26.33
All ras proteins are polyisoprenylated but only some are palmitoylated. Cell (1989) 9.68
Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell (1989) 9.68
Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures. Annu Rev Biochem (1988) 7.57
Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature (1990) 6.71
In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature (1989) 5.08
p21ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci U S A (1989) 4.80
Two genes encode distinct glutamate decarboxylases. Neuron (1991) 3.68
Small GTP-binding proteins in vesicular transport. Trends Biochem Sci (1990) 3.30
Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med (1990) 3.21
The covalent modification of eukaryotic proteins with lipid. J Cell Biol (1987) 3.00
Dynamic fatty acylation of p21N-ras. EMBO J (1987) 2.99
Proteins of synaptic vesicles involved in exocytosis and membrane recycling. Neuron (1991) 2.73
Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J Neurochem (1991) 2.66
Specificity of fatty acid acylation of cellular proteins. J Biol Chem (1985) 2.63
Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature (1982) 2.58
Covalent binding of fatty acid to the transferrin receptor in cultured human cells. J Biol Chem (1981) 2.51
Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels. Nature (1989) 2.50
Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase. J Neurosci (1988) 2.32
Two classes of fatty acid acylated proteins exist in eukaryotic cells. EMBO J (1985) 2.28
Posttranslational membrane attachment and dynamic fatty acylation of a neuronal growth cone protein, GAP-43. J Cell Biol (1989) 2.14
Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest (1987) 2.09
Expression of simian virus 40 T antigen in insect cells using a baculovirus expression vector. Virology (1988) 2.07
Isoprenoid modification of rab proteins terminating in CC or CXC motifs. Proc Natl Acad Sci U S A (1991) 1.99
A simple post-embedding system for the rapid demonstration of tissue antigens under the electron microscope. Histochem J (1983) 1.95
Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci U S A (1992) 1.93
Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci U S A (1991) 1.74
64,000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet (1990) 1.70
C terminus of the small GTP-binding protein smg p25A contains two geranylgeranylated cysteine residues and a methyl ester. Proc Natl Acad Sci U S A (1991) 1.69
Fatty acylation of cellular proteins. Temporal and subcellular differences between palmitate and myristate acylation. J Biol Chem (1986) 1.65
Release of fatty acids from virus glycoproteins by hydroxylamine. Biochim Biophys Acta (1984) 1.59
Pancreatic beta cells express two autoantigenic forms of glutamic acid decarboxylase, a 65-kDa hydrophilic form and a 64-kDa amphiphilic form which can be both membrane-bound and soluble. J Biol Chem (1991) 1.54
Revelation of specificity of 64K autoantibodies in IDDM serums by high-resolution 2-D gel electrophoresis. Unambiguous identification of 64K target antigen. Diabetes (1989) 1.30
Structural and functional considerations of GABA in islets of Langerhans. Beta-cells and nerves. Diabetes (1991) 1.18
Characterization of a cDNA coding for rat glutamic acid decarboxylase. Brain Res Mol Brain Res (1990) 1.15
Regulatory properties of brain glutamate decarboxylase (GAD): the apoenzyme of GAD is present principally as the smaller of two molecular forms of GAD in brain. J Neurosci (1991) 1.13
High concentration of GABA and high glutamate decarboxylase activity in rat pancreatic islets and human insulinoma. Science (1976) 1.07
GABA and glycine in synaptic vesicles: storage and transport characteristics. Neuron (1991) 1.05
Amphiphilic and nonamphiphilic forms of bovine and human dopamine beta-hydroxylase. J Neurochem (1991) 0.90
Tyrosine hydroxylase in secretory granules from bovine adrenal medulla. Evidence for an integral membrane form. J Biol Chem (1990) 0.89
Relative enrichment of the lighter 59 kDa form of glutamic acid decarboxylase in nerve endings: an immunoblotting study in pituitary neurointermediate lobe. Neurosci Lett (1991) 0.78
The etiology of neonatal septal deviations. Facial Plast Surg (1992) 0.78
Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature (1990) 6.71
Local GABA circuit control of experience-dependent plasticity in developing visual cortex. Science (1998) 4.63
Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc Natl Acad Sci U S A (1988) 4.19
Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med (1997) 3.03
Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature (1982) 2.58
Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group. Diabetes Care (2001) 2.37
Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest (1987) 2.09
Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci U S A (1997) 1.97
Good metabolic control is associated with better quality of life in 2,101 adolescents with type 1 diabetes. Diabetes Care (2001) 1.88
Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist. Mol Pharmacol (2001) 1.73
The role of the synthetic enzyme GAD65 in the control of neuronal gamma-aminobutyric acid release. Proc Natl Acad Sci U S A (1999) 1.63
Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets. Diabetes (1993) 1.61
Pancreatic beta cells express two autoantigenic forms of glutamic acid decarboxylase, a 65-kDa hydrophilic form and a 64-kDa amphiphilic form which can be both membrane-bound and soluble. J Biol Chem (1991) 1.54
Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci U S A (1999) 1.50
The midgestational human fetal pancreas contains cells coexpressing islet hormones. Dev Biol (1992) 1.37
Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J Exp Med (1994) 1.36
Pancreatic beta cells cultured from individual preneoplastic foci in a multistage tumorigenesis pathway: a potentially general technique for isolating physiologically representative cell lines. Mol Cell Biol (1993) 1.34
Antibodies to a Mr-64,000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. Diabetologia (1988) 1.32
Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc Natl Acad Sci U S A (1993) 1.32
Coordinate expression of the endogenous p53 gene in beta cells of transgenic mice expressing hybrid insulin-SV40 T antigen genes. EMBO J (1987) 1.32
Autoantibodies to a 64-kilodalton islet cell protein precede the onset of spontaneous diabetes in the BB rat. Science (1984) 1.31
Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes. Diabet Med (1998) 1.29
Glutamate decarboxylase and GABA in pancreatic islets: lessons from knock-out mice. Horm Metab Res (1999) 1.23
High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase. J Mol Biol (1999) 1.16
Increased expression of GAD65 and GABA in pancreatic beta-cells impairs first-phase insulin secretion. Am J Physiol Endocrinol Metab (2000) 1.14
Efavirenz and chronic neuropsychiatric symptoms: a cross-sectional case control study. HIV Med (2006) 1.07
Islet cell surface antibodies and lymphocyte antibodies in the spontaneously diabetic BB Wistar rat. Diabetes (1982) 1.07
Amino acid residues 24-31 but not palmitoylation of cysteines 30 and 45 are required for membrane anchoring of glutamic acid decarboxylase, GAD65. J Cell Biol (1994) 1.07
Expression of major histocompatibility antigens on pancreatic islet cells. Proc Natl Acad Sci U S A (1981) 1.06
Simultaneous visualization of the translocation of protein kinase Calpha-green fluorescent protein hybrids and intracellular calcium concentrations. Biochem J (1999) 1.05
Studies of the isolation and viability of human islets of Langerhans. Transplantation (1988) 1.03
The hydrophilic isoform of glutamate decarboxylase, GAD67, is targeted to membranes and nerve terminals independent of dimerization with the hydrophobic membrane-anchored isoform, GAD65. J Biol Chem (1999) 1.02
Differential expression of neural cell adhesion molecule and cadherins in pancreatic islets, glucagonomas, and insulinomas. Mol Endocrinol (1992) 1.01
Cellular and subcellular localization of an Mr 64,000 protein autoantigen in insulin-dependent diabetes. J Biol Chem (1990) 0.99
Phosphorylation of serine residues 3, 6, 10, and 13 distinguishes membrane anchored from soluble glutamic acid decarboxylase 65 and is restricted to glutamic acid decarboxylase 65alpha. J Biol Chem (1997) 0.99
Islet cell antibodies-theoretical and practical implications. Diabetologia (1981) 0.97
Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase. J Immunol (1996) 0.95
Sub-cellular fractionation of Trypanosoma brucei. Isolation and characterization of plasma membranes. Parasitology (1980) 0.94
Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response study. Dutch Advisory Group on Growth Hormone. J Clin Endocrinol Metab (2000) 0.94
Low prevalence of antibodies to GAD65 in a 50- to 74-year-old general Dutch population. The Hoorn Study. Diabetes Care (1997) 0.93
Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells. Diabetes (1998) 0.92
Glutamic acid decarboxylase antibodies in screening for autoimmune diabetes: influence of comorbidity, age, and sex on specificity and threshold values. Clin Chem (1999) 0.91
Immunoglobulin from insulin-dependent diabetic children inhibits glucose-induced insulin release. Diabetes (1983) 0.90
A non-cleavable mutant of Fas ligand does not prevent neutrophilic destruction of islet transplants. Transplantation (2000) 0.89
Preclinical and manifest diabetes mellitus in young patients with Friedreich's ataxia: no evidence of immune process behind the islet cell destruction. Diabetologia (1989) 0.89
Lessons from the Hvidoere International Study Group on childhood diabetes: be dogmatic about outcome and flexible in approach. Pediatr Diabetes (2013) 0.89
Low prevalence of GAD and IA2 antibodies in schoolchildren from a village in the southwestern section of the Netherlands. Hum Immunol (2001) 0.88
Decreased excitability of the distal motor nerve of young patients with type 1 diabetes mellitus. Pediatr Diabetes (2013) 0.87
Supravital dithizone staining in the isolation of human and rat pancreatic islets. Diabetes Res (1989) 0.86
A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival. Transplantation (2000) 0.85
Specific pancreatic beta-cell surface antigens recognized by a xenogenic antiserum. J Cell Biol (1982) 0.85
Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes. J Clin Invest (1996) 0.85
The 64-kDa beta cell membrane autoantigen and other target molecules of humoral autoimmunity in insulin-dependent diabetes mellitus. Curr Top Microbiol Immunol (1990) 0.84
Transfer of type 1 (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID). Diabetologia (1993) 0.83
Carbohydrate metabolism during growth hormone treatment and after discontinuation of growth hormone treatment in girls with Turner syndrome treated with once or twice daily growth hormone injections. Clin Endocrinol (Oxf) (2000) 0.82
Circulating semicarbazide-sensitive amine oxidase is raised both in type I (insulin-dependent), in type II (non-insulin-dependent) diabetes mellitus and even in childhood type I diabetes at first clinical diagnosis. Diabetologia (1999) 0.82
T cell proliferative responses to glutamic acid decarboxylase-65 in IDDM are negatively associated with HLA DR3/4. Autoimmunity (1995) 0.82
Pancreatic beta cells express two autoantigenic forms of glutamic acid decarboxylase, a 65-kDa hydrophilic form and a 64-kDa amphiphilic form which can be both membrane-bound and soluble. J Biol Chem (1991) 0.81
Islet cell and 64K autoantibodies are associated with plasma IgG in newly diagnosed insulin-dependent diabetic children. J Immunol (1986) 0.81
Absence of a PDX-1 mutation and normal gastroduodenal immunohistology in a child with pancreatic agenesis. Virchows Arch (2000) 0.81
Value of antibodies to GAD65 combined with islet cell cytoplasmic antibodies for predicting IDDM in a childhood population. Diabetologia (1994) 0.81
Islet transplantation in mice differing in the I and S subregions of the H-2 complex. Transplantation (1981) 0.81
Prediction and diagnosis of type 1 diabetes using beta-cell autoantibodies. Clin Lab (2001) 0.81
Carbohydrate metabolism during long-term growth hormone treatment in children with short stature born small for gestational age. Clin Endocrinol (Oxf) (2001) 0.81
Role of islet cell antibodies in the pathogenesis of type I diabetes. Curr Probl Clin Biochem (1983) 0.79
Regulation of GAD expression in rat pancreatic islets and brain by gamma-vinyl-GABA and glucose. Diabetologia (1998) 0.79
The Mental Adjustment to HIV scale: measurement and dimensions of response to AIDS/HIV disease. AIDS Care (1994) 0.79
Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies. Diabetes Care (2001) 0.78
Isolation and characterization of human monoclonal autoantibodies to glutamic acid decarboxylase. Autoimmunity (2002) 0.78
Antibody screening in a population of children. Ann Med (1997) 0.78
Preliminary experience with predictive testing for insulin-dependent diabetes mellitus. Lancet (1995) 0.77
Carbohydrate and lipid metabolism during various growth hormone dosing regimens in girls with Turner syndrome. Dutch Working Group on Growth Hormone. Metabolism (1999) 0.75
Analysis of antibody responses against coxsackie virus B4 protein 2C and the diabetes autoantigen GAD(65). J Med Virol (1999) 0.75
Fluctuations in GAD65 antibodies after clinical diagnosis of IDDM in young children. Diabetes Care (1997) 0.75
Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance. Mol Biol Med (1986) 0.75
[Diabetes, not harmless in young adults]. Ned Tijdschr Geneeskd (2017) 0.75
Development and evaluation of an inventory for rating client satisfaction with outcome in HIV counseling: the Albion Center scale. Patient Educ Couns (1994) 0.75
The glutamate decarboxylase and 38KD autoantigens in type 1 diabetes: aspects of structure and epitope recognition. Autoimmunity (1993) 0.75
Glucose stimulates the biosynthesis of a human pancreatic islet cell protein detected by an antiserum against the human erythrocyte glucose transporter. FEBS Lett (1983) 0.75
[Spontaneous diabetes and diabetes induced by streptozotocin in the rat and mouse]. Journ Annu Diabetol Hotel Dieu (1988) 0.75
Islet-specific immune mechanisms. Diabetes Metab Rev (1987) 0.75
Immunological aspects of type 1 and 2 diabetes mellitus. Adv Exp Med Biol (1985) 0.75
[Mechanism and genetic control of the autoimmune response directed against beta-pancreatic cells in insulin-dependent diabetes]. Journ Annu Diabetol Hotel Dieu (1985) 0.75
Rodent islet cell antigens recognized by antibodies in sera from diabetic patients. Acta Biol Med Ger (1982) 0.75
A beta-cell glycoprotein of Mr 40 000 is the major rat islet cell immunogen following xenogenic immunisation. Diabetologia (1984) 0.75
Islet cell cytoplasmic antibody reactivity in midgestational human fetal pancreas. Acta Diabetol (1994) 0.75
Depression and dietary intake in a cohort of HIV-positive clients in Sydney. Int J STD AIDS (2012) 0.75
Peptide mapping and characterisation of glycation patterns of the glima 38 antigen recognised by autoantibodies in Type I diabetic patients. Diabetologia (2000) 0.75
Enrichment of beta cells from the human fetal pancreas by fluorescence activated cell sorting with a new monoclonal antibody. Diabetologia (1992) 0.75